Calumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Net income
Calumet, Inc.'s net income for fiscal 2025 was −$33.8M, compared with −$222.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$136.8M. Over the past ten years it has ranged from −$328.6M (fiscal 2016) to $48.1M (fiscal 2023); the current reading is higher than 91% of that period. Calumet, Inc. ranks 57th of 60 Specialty Chemicals companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$33.8M | — |
| FY2024 | −$222.0M | — |
| FY2023 | $48.1M | — |
| FY2022 | −$173.3M | — |
| FY2021 | −$260.1M | — |
| FY2020 | −$149.0M | — |
| FY2019 | −$43.6M | — |
| FY2018 | −$55.1M | — |
| FY2017 | −$103.8M | — |
| FY2016 | −$328.6M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | −$95.9M | — |
| Mar 2026 | −$317.0M | — |
| Dec 2025 | −$37.3M | — |
| Sep 2025 | $313.4M | — |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| CBT Cabot Corporation compare | $247.0M |
| FUL H. B. Fuller Company compare | $197.8M |
| AVNT Avient Corporation compare | $182.2M |
| SXT Sensient Technologies Corporation compare | $169.4M |
| HWKN Hawkins, Inc. compare | $85.8M |
| WDFC WD-40 Company compare | $82.3M |
| PRM Perimeter Solutions, SA compare | $55.5M |
| ASH Ashland Inc. compare | $4.0M |
| CLMT Calumet, Inc. | −$136.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on CLMT
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement